XTLB
XTL Biopharmaceuticals Ltd ADR
NASDAQ: XTLB · HEALTHCARE · BIOTECHNOLOGY
$3.90
+9.55% today
Updated 2026-04-30
Market cap
$5.65M
P/E ratio
—
P/S ratio
5.84x
EPS (TTM)
$-3.60
Dividend yield
—
52W range
$2 – $10
Volume
2.3M
XTL Biopharmaceuticals Ltd ADR (XTLB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.47M | $-12.59M | $-21.46M | $-10.58M | $-2.49M | $-735000.00 | $-1.80M | $-1.51M | $-2.50M | $-2.47M | $-1.86M | $-1.73M | $-1.13M | $-816000.00 | $-908000.00 | $-850000.00 | $-1.05M | $-901000.00 | $-707000.00 | $-1.62M |
| Capital expenditures | $38000.00 | $21000.00 | $65000.00 | $2000.00 | $0.00 | $16000.00 | $12000.00 | $86000.00 | $84000.00 | $10000.00 | $66000.00 | $66000.00 | $2000.00 | $2000.00 | $2000.00 | $1000.00 | $0.00 | $0.00 | $0.00 | $54000.00 |
| Depreciation | $242000.00 | $243000.00 | $108000.00 | $39000.00 | $13000.00 | $42000.00 | $94000.00 | $136000.00 | $313000.00 | $53000.00 | $7000.00 | $3000.00 | $1000.00 | $1000.00 | $1000.00 | $1000.00 | $1000.00 | $1000.00 | $0.00 | $199000.00 |
| Stock-based comp | — | $2.18M | $-44000.00 | $345000.00 | — | — | $73000.00 | $1.30M | $-65000.00 | $278000.00 | $148000.00 | $182000.00 | $40000.00 | $24000.00 | $5000.00 | $51000.00 | $37000.00 | $14000.00 | $3000.00 | $264000.00 |
| Free cash flow | $-10.50M | $-12.61M | $-21.52M | $-10.58M | $-2.49M | $-751000.00 | $-1.81M | $-1.59M | $-2.58M | $-2.48M | $-1.93M | $-1.80M | $-1.13M | $-818000.00 | $-910000.00 | $-851000.00 | $-1.05M | $-901000.00 | $-707000.00 | $-1.67M |
| Investing cash flow | $9.53M | $-20.83M | $10.64M | $10.91M | $-24000.00 | $-103000.00 | $-185000.00 | $-1.21M | $3.34M | $1.50M | $-110000.00 | $-66000.00 | $-2.50M | $778000.00 | $2.11M | $32000.00 | $8000.00 | $36000.00 | $41000.00 | $-844000.00 |
| Financing cash flow | $1.51M | $24.46M | $8.80M | $210000.00 | — | $1.48M | $1.74M | $4.28M | $317000.00 | $309000.00 | $3.58M | $0.00 | $4.89M | $385000.00 | $385000.00 | $385000.00 | $385000.00 | $0.00 | $0.00 | $1.45M |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |